# Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery

> **NCT07271875** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 560 (estimated)

## Conditions studied

- Postoperative Gastrointestinal Dysfunction (POGD)
- Postoperative Ileus
- Colorectal Surgery

## Interventions

- **DRUG:** Neostigmine + Atropine
- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT07271875
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 560 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07271875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07271875, "Neuromuscular Blocking Agents on Gastrointestinal Function Following Colorectal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07271875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*